The effect of health promotion awareness counseling with stress management on anxiety and reproductive and sexual self-care performance in women with human papiloma virus

Not Applicable

Recruiting

• Conditions: anxiety.; Anxiety disorder due to known physiological condition; F06.4

• Registration Number: IRCT20111122008170N14
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 64

Inclusion Criteria

Women with positive HPV test results and low-risk and high-risk groups
Anxiety score 32-64
Having a contact number for follow-up
Literacy for reading and writing

Exclusion Criteria

Cancer disease or its history
History of participating in previous training and intervention programs related to sexual health and fertility
intellectual disability
Any mental illness according to the person's statement
Any recent unfortunate incident including the loss of a loved one within the last 6 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average anxiety score. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: Spielberger anxiety questionnaire.;Mean score of fertility and sexual self-care performance. Timepoint: Before the intervention and 4 weeks after the intervention. Method of measurement: assessment questionnaire Reproductive and sexual self-care.

Secondary Outcome Measures

Name	Time	Method
Sexual health literacy. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: Sexual health literacy questionnaire for adults, SHALE.;Quality of Life. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: Quality of life questionnaire for women with HPV (HPV-QoL Human Papilloma Viral questionnaire).;Stress. Timepoint: Before the intervention and 4 weeks after the study. Method of measurement: DASS-21 questionnaire.